|
|
Article: A Novel Gene-Silencing Protein Offers New Possibilities for Treatment of Cancer and Genetic Disorders.
- Article from:
- Cancer Weekly
- Article date:
- November 10, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
A study published recently in the Proceedings of the National Academy of Science (PNAS) by a team of scientists headed by Professors Helene Bierne and Pascale Cossart from the Pasteur Institute, in collaboration with colleagues form the CNRS and the French Agricultural Research Institute (INRA), identified a novel protein, BAHD1, which is responsible for changing DNA structure and silencing the expression of genes. Expression of pathological variants of genes may play a key role in causing various cancers and genetic disorders. The finding is part of the Spatelis research project, funded under the framework of ERA-NET PathoGenoMics, an initiative of the European Commission ...